PURPOSE: In this feasibility study, a 5- to 6-year clinical follow-up evaluation was conducted on 8 patients who had undergone reconstruction of 1 injured medial meniscus with a tissue-engineered collagen meniscus implant. The hypothesis was that these patients would show significant clinical improvement over their preoperative status and would have maintained their status determined at the 2-year follow-up evaluation. TYPE OF STUDY: Prospective longitudinal feasibility study follow-up evaluation. METHODS: Eight patients underwent arthroscopic placement of a collagen meniscus implant by a single surgeon to reconstruct and restore the irreparably damaged medial meniscus of 1 knee. All patients returned for clinical, radiographic, magnetic resonance imaging, and arthroscopic examinations an average of 5.8 years (range, 5.5-6.3 y) after collagen meniscus implant placement. RESULTS: Lysholm scores improved significantly (P = .045) from 75 preoperatively to 88 at most recent follow-up evaluation. Average Tegner activity scores improved significantly (P = .001) from 3 to 6. Patient self-assessment improved significantly (P = .046) from 2.4 to 1.9 (1 = normal, 4 = severely abnormal). Pain scores improved from 23 to 11 (0 = no pain, 100 = worst pain). Imaging studies confirmed that the chondral surfaces of the medial compartment had not degenerated further since the placement of the implant 5.8 years earlier. Relook arthroscopy with direct measurement of the newly generated tissue revealed 69% defect filling. Histologic assessment of tissue biopsy specimens from 3 patients showed the presence of fibrocartilage with a uniform extracellular matrix. CONCLUSIONS: The meniscus-like tissue that developed after collagen meniscus implant placement has maintained its structure and functioned without negative effects for more than 5 years. The hypothesis was affirmed that these patients were improved significantly compared with their preoperative status and unchanged compared with 2-year evaluations. LEVEL OF EVIDENCE: Level IV.
PURPOSE: In this feasibility study, a 5- to 6-year clinical follow-up evaluation was conducted on 8 patients who had undergone reconstruction of 1 injured medial meniscus with a tissue-engineered collagen meniscus implant. The hypothesis was that these patients would show significant clinical improvement over their preoperative status and would have maintained their status determined at the 2-year follow-up evaluation. TYPE OF STUDY: Prospective longitudinal feasibility study follow-up evaluation. METHODS: Eight patients underwent arthroscopic placement of a collagen meniscus implant by a single surgeon to reconstruct and restore the irreparably damaged medial meniscus of 1 knee. All patients returned for clinical, radiographic, magnetic resonance imaging, and arthroscopic examinations an average of 5.8 years (range, 5.5-6.3 y) after collagen meniscus implant placement. RESULTS: Lysholm scores improved significantly (P = .045) from 75 preoperatively to 88 at most recent follow-up evaluation. Average Tegner activity scores improved significantly (P = .001) from 3 to 6. Patient self-assessment improved significantly (P = .046) from 2.4 to 1.9 (1 = normal, 4 = severely abnormal). Pain scores improved from 23 to 11 (0 = no pain, 100 = worst pain). Imaging studies confirmed that the chondral surfaces of the medial compartment had not degenerated further since the placement of the implant 5.8 years earlier. Relook arthroscopy with direct measurement of the newly generated tissue revealed 69% defect filling. Histologic assessment of tissue biopsy specimens from 3 patients showed the presence of fibrocartilage with a uniform extracellular matrix. CONCLUSIONS: The meniscus-like tissue that developed after collagen meniscus implant placement has maintained its structure and functioned without negative effects for more than 5 years. The hypothesis was affirmed that these patients were improved significantly compared with their preoperative status and unchanged compared with 2-year evaluations. LEVEL OF EVIDENCE: Level IV.
Authors: James H Lubowitz; Peter C M Verdonk; John B Reid; René Verdonk Journal: Knee Surg Sports Traumatol Arthrosc Date: 2007-02-28 Impact factor: 4.342
Authors: Karl F Schüttler; Felix Haberhauer; Markus Gesslein; Thomas J Heyse; Jens Figiel; Olaf Lorbach; Turgay Efe; Philip P Roessler Journal: Knee Surg Sports Traumatol Arthrosc Date: 2015-08-23 Impact factor: 4.342